Ibrutinib Versus Temsirolimus in Patients with Relapsed or Refractory Mantle-Cell Lymphoma: an International, Randomised, Open-Label, Phase Study

AuthID
P-00K-7CK
23
Author(s)
Dreyling, M
·
Jurczak, W
·
Jerkeman, M
·
Silva, RS
·
Rusconi, C
·
Offner, F
·
Caballero, D
·
Joao, C
·
[+3]·
Goldberg, JD
·
Enny, C
·
Traina, S
·
Balasubramanian, S
·
Bandyopadhyay, N
·
Sun, S
·
Vermeulen, J
·
Rizo, A
·
Document Type
Article
Year published
2016
Published
in LANCET, ISSN: 0140-6736
Volume: 387, Issue: 10020, Pages: 770-778 (9)
Indexing
Publication Identifiers
Scopus: 2-s2.0-84959074796
Wos: WOS:000370418000036
Source Identifiers
ISSN: 0140-6736
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.